Martin Lehr

Independent Director

Mr. Lehr is co-founder and CEO of Context Therapeutics, a clinical-stage biopharmaceutical company. Previously, he was a founding team member at Osage University Partners, a venture capital firm focused on academic spinouts. Earlier in his career, Mr. Lehr conducted research in DNA repair at the Sloan Kettering Institute and in thrombosis and hemostasis at the Children's Hospital of Philadelphia.

‍Mr. Lehr also serves on the board of CureDuchenne Ventures and is a Director of BioBreak, a national biotech executive networking group with over 2,500 members. He also serves on the Advisory Boards of Life Science Cares and Life Science Leader magazine.

Mr. Lehr holds an M.A. in Biotechnology from Columbia University and a B.A. in Economics from the University of Pennsylvania.